News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
254,013 Results
Type
Article (17402)
Company Profile (73)
Press Release (236538)
Section
Business (78596)
Career Advice (563)
Deals (21647)
Drug Delivery (27)
Drug Development (23381)
Employer Resources (39)
FDA (6466)
Job Trends (6824)
News (133436)
Policy (13190)
Tag
Academia (1165)
Alliances (24618)
Alzheimer's disease (390)
Antibody-drug conjugate (ADC) (38)
Approvals (6463)
Artificial intelligence (68)
Bankruptcy (128)
Best Places to Work (5398)
Biotechnology (53)
Breast cancer (52)
Cancer (458)
Cardiovascular disease (36)
Career advice (502)
Cell therapy (73)
Clinical research (18421)
Collaboration (242)
COVID-19 (1014)
Data (416)
Diabetes (46)
Diagnostics (3906)
Drug discovery (33)
Earnings (28015)
Employer resources (35)
Events (24553)
Executive appointments (117)
FDA (6693)
Funding (147)
Gene therapy (57)
GLP-1 (306)
Government (2065)
Healthcare (6619)
Infectious disease (1043)
Inflammatory bowel disease (38)
Interviews (81)
IPO (6008)
Job creations (1643)
Job search strategy (432)
Layoffs (151)
Legal (3015)
Lung cancer (81)
Manufacturing (87)
Medical device (4953)
Medtech (4954)
Mergers & acquisitions (15767)
Metabolic disorders (138)
Neuroscience (489)
NextGen Class of 2024 (2450)
Non-profit (1417)
Northern California (485)
Obesity (87)
Opinion (80)
People (20076)
Phase I (5211)
Phase II (7626)
Phase III (7029)
Pipeline (219)
Postmarket research (872)
Preclinical (2467)
Radiopharmaceuticals (96)
Rare diseases (76)
Real estate (2911)
Regulatory (8674)
Research institute (1113)
Resumes & cover letters (89)
Southern California (398)
Startups (1548)
United States (4651)
Vaccines (165)
Weight loss (71)
Date
Today (18)
Last 7 days (213)
Last 30 days (1371)
Last 365 days (13305)
2024 (12304)
2023 (14837)
2022 (21185)
2021 (22378)
2020 (21950)
2019 (17627)
2018 (13838)
2017 (13176)
2016 (12463)
2015 (14432)
2014 (10791)
2013 (9091)
2012 (9584)
2011 (10171)
2010 (9077)
Location
Africa (297)
Arizona (57)
Asia (16078)
Australia (2481)
California (1055)
Canada (491)
China (90)
Colorado (44)
Connecticut (54)
Europe (36732)
Florida (192)
Georgia (37)
Illinois (101)
Indiana (80)
Japan (36)
Kansas (35)
Maryland (302)
Massachusetts (746)
Michigan (79)
Minnesota (62)
New Jersey (393)
New York (329)
North Carolina (308)
Northern California (485)
Ohio (64)
Pennsylvania (267)
South America (450)
Southern California (398)
Texas (159)
Utah (41)
Washington State (105)
254,013 Results for "adac laboratories acquired by royal philips electronics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Philips completes cancellation of 4.4 million shares
Royal Philips announced that it has completed the cancellation of 4,437,164 of its shares.
June 19, 2024
·
1 min read
Business
Philips shareholders approve all proposals at the AGM 2024
Royal Philips, announced that its shareholders approved all proposals at the Annual General Meeting of Shareholders 2024, including:
May 7, 2024
·
4 min read
Philips announces exchange ratio for 2023 dividend
Royal Philips, announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares.
May 15, 2024
·
2 min read
Business
Philips publishes its Annual Report 2023
Royal Philips, a global leader in health technology, published its Annual Report 2023.
February 20, 2024
·
2 min read
Genetown
Philips presents study results at Heart Rhythm Annual Meeting demonstrating benefits of its AI-powered cardiac monitoring solutions
Royal Philips a global leader in health technology, is presenting new retrospective study results demonstrating the clinical and economic benefits of Philips’ AI-powered cardiac care solutions at the Heart Rhythm Annual Meeting in Boston.
May 17, 2024
·
6 min read
Philips convenes the Annual General Meeting of Shareholders 2024
Royal Philips, announced it has convened the Annual General Meeting of Shareholders 2024 and published the agenda with explanatory notes.
March 22, 2024
·
2 min read
Philips Zenition 90 Motorized receives FDA 510(k) clearance, helping clinicians deliver high quality care with a high-powered and fast motorized mobile C-arm
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Philips Image Guided Therapy Mobile C-arm System 9000 – Zenition 90 Motorized, designed to help clinicians deliver high-quality care to more patients.
June 17, 2024
·
4 min read
Philips delivers strong ESG performance in 2023
Royal Philips, a global leader in health technology, has relentlessly focused on further improving its Environmental, Social, and Governance performance in 2023.
February 20, 2024
·
6 min read
Philips ePatch and AI analytics platform rolled out to 14 hospitals across Spain to monitor heart patients
Royal Philips, a global leader in health technology, announced the successful nationwide rollout of its ambulatory cardiac monitoring service in Spain using its unique wearable ePatch paired with its AI-driven Cardiologs analytics platform.
May 22, 2024
·
5 min read
Philips Respironics reaches agreement with US government on a consent decree creating a clear path forward
Following the FDA’s inspection of Philips Respironics’ facility in Murrysville in 2021 and the subsequent inspectional observations, the US Department of Justice, representing the US Food and Drug Administration, began discussions with Royal Philips in July 2022 regarding the terms of a proposed consent decree.
April 10, 2024
·
6 min read
1 of 25,402
Next
